Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05766410
Status:
RECRUITING
Last Update Posted:
2023-03-16
First Post:
2023-02-03
Brief Title:
A Randomized Study Comparing the Immune Modulation Effect of Ribociclib Palbociclib and Abemaciclib in ERHER2- EBC
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Organization Data
Organization:
National Taiwan University Hospital
Class:
OTHER
Study ID:
202207200MIPB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Taiwan University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None